This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Biogen Ma Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Shantanu Sule: Innovator in Pharmaceutical Compositions
Introduction
Shantanu Sule is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating Alzheimer's disease and related disorders.
Latest Patents
Shantanu Sule holds 1 patent for his work on pharmaceutical compositions containing anti-beta amyloid antibodies. This patent focuses on the use of these compositions in addressing the abnormal accumulation of beta amyloid in the central nervous system, which is associated with mild cognitive impairment and Alzheimer's disease.
Career Highlights
Sule is currently employed at Biogen MA Inc., a leading biotechnology company known for its innovative approaches to neurological diseases. His work at Biogen has positioned him at the forefront of research aimed at combating Alzheimer's disease.
Collaborations
Throughout his career, Shantanu has collaborated with talented professionals such as Kapil Gupta and Adnan Zunic. These collaborations have further enhanced the impact of his research and innovations in the pharmaceutical field.
Conclusion
Shantanu Sule's contributions to pharmaceutical compositions represent a significant advancement in the treatment of Alzheimer's disease. His innovative work continues to inspire progress in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile